Drug Trial Radar · NCT07442071
Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome
Last checked: Nov 19, 2026Latest source record: Mar 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
4,336
Planned (sponsor's estimate)
Start
Jun 2026
Primary completion
Jul 2030
Study completion Jul 2030
Sponsor
- Lead sponsor
- Central Hospital, Nancy, FranceAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will test whether a lower dose of epinephrine (0.5 mg) given during emergency treatment for out-of-hospital cardiac arrest helps more patients survive with good brain function, compared to the standard dose (1 mg). Adults who experience cardiac arrest outside the hospital and are treated by emergency medical teams will be randomly assigned to receive either the low dose or the standard dose of epinephrine. The study will compare survival and neurological outcomes between the two groups over 28 days.
Conditions
- Out-of-hospital Cardiac Arrest (OHCA)
Interventions
Epinephrine 0.5 mg intravenous bolusDrug
Epinephrine 0.5 mg/mL solution for injection, administered as a 0.5 mg intravenous bolus every 3 to 5 minutes during cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest. T
Epinephrine 1 mg intravenous bolusDrug
Epinephrine 1 mg/mL solution for injection, administered as a 1 mg intravenous bolus every 3 to 5 minutes during cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Modified Rankin Scale (mRS) scoreTime frame: 28-day
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
CH Annecy
Annecy, France
Centre hospitalier de la Côte Basque
Bayonne, France
CHU Besancon
Besançon, France
CHU Brest
Brest, France
CHU Colmar
Colmar, France
CH SUD Francilien
Corbeil-Essonnes, France
Brigade de Sapeurs-Pompiers de Paris
Courbevoie, France
Centre Hospitalier Universitaire Grenoble Alpes
La Tronche, France
Hospices Civils De Lyon
Lyon, France
CHU Montpellier
Montpellier, France
CHRU Nancy
Nancy, France
Centre Hospitalier Universitaire De Nantes
Nantes, France
CHU Nice
Nice, France
CHU Nimes
Nîmes, France
AP-HP Hôpital Necker
Paris, France
Hopital Beaujon
Paris, France
hôpital Lariboisière
Paris, France
La Pitié Salpêtrière
Paris, France
Raymond Poincaré Hospital
Paris, France
CHU Poitiers
Poitiers, France
Centre Hospitalier Universitaire Reims
Reims, France
CHU Rennes
Rennes, France
CHU Rouen
Rouen, France
Centre hospitalier Annecy Genevois Site Julien en GENEVOIS
Saint-Julien-en-Genevois, France
Centre Hospitalier Universitaire De Toulouse
Toulouse, France
CHU Tours
Tours, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.